Sternocleidomastoid Thickness in Sarcopenia

StatusTerminated
PhaseNot specified
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status changed: Not Yet Recruiting → Terminated Sponsor's reason: Due to an overly detailed methodology and strict inclusion/exclusion criteria, patient recruitment was insufficient (poor accrual), leading to early termination of the study. Show 6 more changesShow less
    • Primary completion date changed from estimate of Feb 1, 2026 to Sep 1, 2026
    • Study completion date changed from estimate of Feb 15, 2026 to Sep 15, 2026
    • Final enrollment: 20 participants (planned 80)
    • Eligibility criteria expanded, about 6 words
    • Site contact updated
    • Publications: details revised at 2 of 2 entries
  2. Start date: Jan 1, 2025 to Sep 1, 2025
    • Primary completion date: Jan 1, 2026 to Feb 1, 2026
    • Study completion date: Jan 15, 2026 to Feb 15, 2026
    v5
  3. Primary completion date: Feb 15, 2024 to Jan 1, 2026v4 Show 4 more changesShow less
    • Start date: Jul 15, 2023 to Jan 1, 2025
    • Trial status: Recruiting to Not Yet Recruiting
    • Study completion date: Feb 28, 2024 to Jan 15, 2026
    • Site details revised
  4. Trial status: Not Yet Recruiting to Recruiting
    • Site details revised
    v3
  5. Secondary endpoints: details revised at 1 of 2 entriesv2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
In order to prevent sarcopenia in intensive care patients and to guide nutritional therapy, evaluation of muscle thickness with ultrasonography is a modern, simple and non-invasive procedure routinely performed by Anesthesiology and Reanimation specialists. Sarcopenia in intensive care patients has been demonstrated in many studies. It has been studied that routine examination of changes in rectus femoris muscle thickness by ultrasonography is a predictor of sarcopenia. However, the muscles in the neck region, such as the sternocleidomastoid muscle, which are easy to examine, have not been studied very well. There is no study in the literature with the sternocleidomastoid muscle. For this reason, we decided to examine the relationship of sternocleidomastoid muscle thickness with patient characteristics, treatments, feeding route and type, feeding time, length of stay in intensive care unit, as in routine measurements of rectus femoris muscle thickness by ultrasonography.
Trial Details
NCT Number NCT05928845
Lead Sponsor Namik Kemal University
Conditions
(from sponsor)		 Sarcopenia
Related terms Sarcopenia
Enrollment 20 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov